Tanaka Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Tanaka Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10K	Hold	166	–	–	0.02%	34
2025 Q4	$9K	Hold	166	–	–	0.02%	36
2025 Q3	$7K	Buy	+166	New	+$7.75K	0.01%	38
2025 Q1	$10K	Hold	166	–	–	0.02%	34
2024 Q4	$9K	Hold	166	–	–	0.02%	36
2024 Q3	$9K	Sell	166 -320	-66%	-$15K	0.02%	38
2024 Q2	$20K	Hold	486	–	–	0.05%	36
2024 Q1	$26K	Hold	486	–	–	0.06%	35
2023 Q4	$25K	Hold	486	–	–	0.06%	35
2023 Q3	$28K	Hold	486	–	–	0.08%	31
2023 Q2	$31K	Hold	486	–	–	0.08%	33
2023 Q1	$34K	Hold	486	–	–	0.1%	33
2022 Q4	$35K	Hold	486	–	–	0.11%	31
2022 Q3	$35K	Hold	486	–	–	0.1%	30
2022 Q2	$37K	Hold	486	–	–	0.12%	31
2022 Q1	$35K	Sell	486 -266	-35%	-$17.9K	0.07%	36
2021 Q4	$47K	Sell	752 -640	-46%	-$37.5K	0.09%	36
2021 Q3	$82K	Hold	1,392	–	–	0.12%	35
2021 Q2	$93K	Hold	1,392	–	–	0.13%	33
2021 Q1	$88K	Hold	1,392	–	–	0.11%	34
2020 Q4	$86K	Sell	1,392 -215	-13%	-$13.2K	0.19%	32
2020 Q3	$97K	Sell	1,607 -70	-4%	-$4.21K	0.3%	33
2020 Q2	$99K	Hold	1,677	–	–	0.31%	33
2020 Q1	$93K	Hold	1,677	–	–	0.41%	30
2019 Q4	$108K	Buy	+1,677	New	+$96K	0.34%	31

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tanaka Capital Management's BMY Position: Q1 2026 in Review

Tanaka Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 166 shares worth $10K. The position accounts for 0.02% of the portfolio, ranked #34.

Tanaka Capital Management first reported a position in BMY in Q4 2019 and has held it in 25 quarters since. The position peaked at $108K in Q4 2019. 2,538 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Tanaka Capital Management held 166 shares of Bristol-Myers Squibb worth $10K as of Q1 2026.
Tanaka Capital Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.02% of Tanaka Capital Management's portfolio in Q1 2026, its #34 holding.
Tanaka Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 25 quarters since.
Tanaka Capital Management's Bristol-Myers Squibb position peaked at $108K in Q4 2019.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Tanaka Capital Management's 13F filing for Q1 2026, filed 18 May 2026.